{"id":18983,"date":"2022-01-18T08:55:23","date_gmt":"2022-01-18T07:55:23","guid":{"rendered":"https:\/\/www.idisantiago.es\/grupo-de-investigacion\/e034-farmacologia-clinica\/"},"modified":"2026-04-06T09:56:27","modified_gmt":"2026-04-06T07:56:27","slug":"e034-farmacologia-clinica","status":"publish","type":"project","link":"https:\/\/www.idisantiago.es\/en\/grupo-de-investigacion\/e034-farmacologia-clinica\/","title":{"rendered":"E034 &#8211; FarmaCHUSLab"},"content":{"rendered":"<p>[et_pb_section fb_built=&#8221;1&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; custom_padding=&#8221;0px||||false|false&#8221; da_disable_devices=&#8221;off|off|off&#8221; global_colors_info=&#8221;{}&#8221; da_is_popup=&#8221;off&#8221; da_exit_intent=&#8221;off&#8221; da_has_close=&#8221;on&#8221; da_alt_close=&#8221;off&#8221; da_dark_close=&#8221;off&#8221; da_not_modal=&#8221;on&#8221; da_is_singular=&#8221;off&#8221; da_with_loader=&#8221;off&#8221; da_has_shadow=&#8221;on&#8221;][et_pb_row _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; width=&#8221;100%&#8221; custom_padding=&#8221;0px||||false|false&#8221; locked=&#8221;on&#8221; collapsed=&#8221;on&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<p>\u00c1REA: <a href=\"https:\/\/www.idisantiago.es\/en\/research-areas-2\/a005-plataformas-y-metodologia\/\">PLATAFORMAS Y METODOLOG\u00cdA<\/a><\/p>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=&#8221;2_3,1_3&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; width=&#8221;100%&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;2_3&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_image src=&#8221;https:\/\/www.idisantiago.es\/wp-content\/uploads\/2023\/10\/FARM.inv_.Premio-NAcional23_20231011_122841_0094-scaled.jpg&#8221; title_text=&#8221;FARM.inv.Premio NAcional23_20231011_122841_0094&#8243; _builder_version=&#8221;4.21.0&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][\/et_pb_image][et_pb_toggle title=&#8221;Objectives and lines of research&#8221; admin_label=&#8221;Objetivos y l\u00edneas de investigaci\u00f3n&#8221; _builder_version=&#8221;4.19.4&#8243; _module_preset=&#8221;default&#8221; body_font=&#8221;|300|||||||&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h3>Objectives<\/h3>\n<p>In the field of clinical and translational research, the interests of our research group, made up mainly of members of the Pharmacy Service of the Santiago de Compostela Health Area with research and care training, are oriented towards a series of fundamental aspects:<br \/>1.Personalization of pharmacological treatments: contribute to revealing the bases of variability in the response to drugs and optimize the results of pharmacological therapies.<br \/>2. Development and galenic characterization of medicines<\/p>\n<h3>Lines of research<\/h3>\n<ul>\n<li><strong>Development of drugs and personalized formulations (Galeno 4.0):<\/strong> Currently there is a significant number of patients with no treatment available, who do not have treatments adapted to their disease and\/or specific condition. At this point, the galenic sections of the Pharmacy Service are in charge of responding. The &#8220;Galeno 4.0&#8221; line has meant a reinvention in the development and optimization of personalized formulations adapted to the patient, and the group is currently a national benchmark in this field. All the results obtained in this line have had a direct transfer to our clinical care practice.<\/li>\n<li><strong>Pharmacokinetic personalized medicine:<\/strong> According to the Canadian National Research Council, Personalized Medicine supposes the adaptation of medical treatment to the individual characteristics of each patient. This implies the possibility of identifying patients who differ in their susceptibility to experience a certain disease, in the biology and\/or prognosis of said disease, as well as in the response or adverse effects that they experience after the administration of a certain treatment. This identification is made through the analysis and integration of genomic data and molecular imaging techniques with clinical data and the patient&#8217;s environment.<\/li>\n<li><strong>Independent clinical research:<\/strong> Clinical trials are considered essential to advance scientific research. Thanks to them, new medicines and treatments may be available, but their implementation and execution is expensive for this reason, in more than 70% of cases they are usually promoted by the industry. In recent years, the unit has coordinated several of these trials; however, in recent years the need to promote independent clinical research has arisen, which attempts to solve problems identified by professionals of the National Health System that affect their patients. Leading innovation in the area of \u200b\u200bdrug development and the application of personalized medicine techniques inherently includes the clinical evaluation of these interventions. Currently, the unit has coordinated the conduct of clinical trials promoted by the industry, and leads two clinical trials independent in the field of infectious diseases.<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p>[\/et_pb_toggle][et_pb_toggle title=&#8221;Research team&#8221; admin_label=&#8221;Equipo investigador&#8221; _builder_version=&#8221;4.21.0&#8243; _module_preset=&#8221;default&#8221; body_font=&#8221;|300|||||||&#8221; hover_enabled=&#8221;0&#8243; global_colors_info=&#8221;{}&#8221; sticky_enabled=&#8221;0&#8243;]<\/p>\n<table style=\"width: 100%; border-collapse: collapse; border-style: hidden;\" border=\"0\">\n<tbody>\n<tr>\n<td style=\"width: 50%;\"><strong>Leader<\/strong><br \/>Fern\u00e1ndez Ferreiro, Anxo<\/p>\n<p>&nbsp;<\/p>\n<p><strong>Coleader\u00a0<\/strong><br \/>Mondelo Garc\u00eda, Cristina<\/p>\n<p>&nbsp;<\/p>\n<p><strong>Members<\/strong><br \/>Almu\u00ed\u00f1a Varela, Pablo<br \/>\u00c1lvarez Barrios, Ana<br \/>Band\u00edn Vilar, Enrique Jos\u00e9<br \/>Bern\u00e1rdez Ferr\u00e1n, Beatriz<br \/>Busto Iglesias, Manuel<br \/>Cajade Pascual, Francisco<br \/>Carpintero Maggiori, Charo Andrea<br \/>Castro Balado, Ana<br \/>Castro Fern\u00e1ndez, Diana Carolina<br \/>Cuartero Mart\u00ednez, Andrea<br \/>Dom\u00ednguez Santana, Carmen Mar\u00eda<br \/>Dur\u00e1n Pi\u00f1eiro, Goretti<br \/>Feij\u00f3o Vilanova, Pablo<br \/>Feitosa Medeiros, Ana Carolina<br \/>Fraga Codesido, J\u00e9ssica<br \/>Garc\u00eda Quintanilla, Laura<br \/>Gil Mart\u00ednez, Mar\u00eda<\/p>\n<\/td>\n<td style=\"width: 50%;\">Gir\u00e1ldez Montero, Jos\u00e9 Mar\u00eda<br \/>Gonz\u00e1lez Barcia, Miguel<br \/>Gonz\u00e1lez L\u00f3pez, Jaime<br \/>Hermelo Vidal, Gonzalo<br \/>Mart\u00ednez Guiti\u00e1n, Marta<br \/>Rodr\u00edguez Fern\u00e1ndez, Carmen Ant\u00eda<br \/>Rodr\u00edguez Mart\u00ednez, Lorena<br \/>Toja Camba, Francisco Jos\u00e9<br \/>Varela Rey, Iria<br \/>Vidal Millares, Mar\u00eda<br \/>Zarra Ferro, Irene<\/p>\n<p>&nbsp;<\/p>\n<p><strong>External Collaborator Staff<\/strong><br \/>Lamas D\u00edaz, Mar\u00eda Jes\u00fas<\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>[\/et_pb_toggle][et_pb_toggle title=&#8221;Projects&#8221; disabled_on=&#8221;off|off|off&#8221; admin_label=&#8221;Proyectos (cambiar s\u00f3 codigo IDIS)&#8221; _builder_version=&#8221;4.19.4&#8243; _module_preset=&#8221;default&#8221; body_font=&#8221;|300|||||||&#8221; locked=&#8221;off&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<strong>Determinaci\u00f3n prote\u00f3mica del efecto de la cisteamina a nivel molecular en c\u00e9lulas de pacientes con cistinosis nefrop\u00e1tica<\/strong><br \/>C\u00f3digo del proyecto: PROTEOCYST<br \/>Entidad financiadora: Colegio de farmac\u00e9uticos de Sevilla<br \/>Duraci\u00f3n: 2023<br \/>Cuant\u00eda: 6 000 EUR<br \/>Investigador\/a principal: <a href=\"\"><\/a> Jes\u00fas Mateos Mart\u00edn<br \/><\/p>\n<p><strong>Farmacocin\u00e9tica, prote\u00f3mica e imagen molecular en la individualizaci\u00f3n terap\u00e9utica de linezolid en infecciones osteoarticulares<\/strong><br \/>C\u00f3digo del proyecto: PI22\/00038<br \/>Entidad financiadora: Instituto de Salud Carlos III<br \/>Duraci\u00f3n: 2023-2025<br \/>Cuant\u00eda: 48 400 EUR<br \/>Investigador\/a principal: <a href=\"\"><\/a> Cristina Mondelo Garc\u00eda<br \/><\/p>\n<p><strong>La investigaci\u00f3n traslacional en la optimizaci\u00f3n terap\u00e9utica de la queratoconjuntivitis vernal con tacrolimus oft\u00e1lmico \u201cOFTAC-VER\u201d<\/strong><br \/>C\u00f3digo del proyecto: FEFH2022<br \/>Entidad financiadora: Fundaci\u00f3n Espa\u00f1ola de Farmacia Hospitalaria<br \/>Duraci\u00f3n: 2022-2023<br \/>Cuant\u00eda: 14 500 EUR<br \/>Investigador\/a principal: <a href=\"\"><\/a> Ana Castro Balado<br \/><\/p>\n<p><strong>STOP CISTINOSIS. Nuevas DianaS moleculares identificadas por proTeOmica y rePosicionamiento de f\u00e1rmacos en el tratamiento de la cistinosis Infantil<\/strong><br \/>C\u00f3digo del proyecto: MUTUA22<br \/>Entidad financiadora: Fundaci\u00f3n Mutua Madrile\u00f1a<br \/>Duraci\u00f3n: 2022-2025<br \/>Cuant\u00eda: 120 750 EUR<br \/>Investigador\/a principal: <a href=\"\"><\/a> <br \/><\/p>\n<p>\n<p>[\/et_pb_toggle][et_pb_toggle title=&#8221;Publications&#8221; disabled_on=&#8221;off|off|off&#8221; admin_label=&#8221;Publicaciones&#8221; _builder_version=&#8221;4.21.0&#8243; _module_preset=&#8221;default&#8221; body_font=&#8221;|300|||||||&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<ul>\n<li>Varela Rey I, Band\u00edn Vilar EJ, Cant\u00f3n Blanco A, Martinon Torres N, Amoedo Fari\u00f1a B, Gayoso Gonz\u00e1lez D, Barrientos Lema I, de Moura Ramos JJ, Zarra Ferro I, Gonz\u00e1lez Barcia M, Mondelo Garc\u00eda C, Mart\u00ednez Olmos M\u00c1, Fern\u00e1ndez Ferreiro A. <strong>NEmecum: digital tool to help the prescription and dispensation of enteral nutrition and infant nutrition formulas. Development, diffusion and analysis of results and usage data. <\/strong><em>Nutr Hosp.<\/em> 2023 Aug 30. <span style=\"color: #808000;\"><strong><a style=\"color: #808000;\" href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/37705457\/\">doi: 10.20960\/nh.04720<\/a><\/strong><\/span>. Online ahead of print. PMID: 37705457<\/li>\n<li>Rodr\u00edguez-Mart\u00ednez L, Castro-Balado A, Hermelo-Vidal G, Band\u00edn-Vilar E, Varela-Rey I, Toja-Camba FJ, Rodr\u00edguez-Jato T, Novo-Veleiro I, Varela-Garc\u00eda PM, Zarra-Ferro I, Gonz\u00e1lez-Barcia M, Mondelo-Garc\u00eda C, Mateos J, Fern\u00e1ndez-Ferreiro A. <strong>Ampicillin Stability in a Portable Elastomeric Infusion Pump: A Step Forward in Outpatient Parenteral Antimicrobial Therapy.<\/strong> <em>Pharmaceutics<\/em>. 2023 Aug 8;15(8):2099. <span style=\"color: #808000;\"><strong><a style=\"color: #808000;\" href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/37631313\/#new_tab\">doi: 10.3390\/pharmaceutics15082099<\/a><\/strong><\/span>. PMID:\u00a037631313<\/li>\n<li>Busto-Iglesias M, Rodr\u00edguez-Mart\u00ednez L, Rodr\u00edguez-Fern\u00e1ndez CA, Gonz\u00e1lez-L\u00f3pez J, Gonz\u00e1lez-Barcia M, de Domingo B, Rodr\u00edguez-Rodr\u00edguez L, Fern\u00e1ndez-Ferreiro A, Mondelo-Garc\u00eda C. <strong>Perspectives of Therapeutic Drug Monitoring of Biological Agents in Non-Infectious Uveitis Treatment: A Review.<\/strong> <em>Pharmaceutics<\/em>. 2023 Feb 25;15(3):766. <span style=\"color: #808000;\"><strong><a style=\"color: #808000;\" href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/36986627\/#new_tab\">doi: 10.3390\/pharmaceutics15030766<\/a><\/strong><\/span>. PMID: 36986627<\/li>\n<li>Castro-Balado A, Novo-Veleiro I, V\u00e1zquez-Agra N, Barbeito-Casti\u00f1eiras G, Estany-Gestal A, Trastoy-Pena R, Gonz\u00e1lez-Barcia M, Zarra-Ferro I, Del R\u00edo-Garma MC, Crespo-Diz C, Delgado-S\u00e1nchez O, Otero-Espinar FJ, Mondelo-Garc\u00eda C, Pose-Reino A, Fern\u00e1ndez-Ferreiro A. <strong>Efficacy and Safety of Inhaled Ethanol in Early-Stage SARS-CoV-2 Infection in Older Adults: A Phase II Randomized Clinical Trial. <\/strong><em>Pharmaceutics<\/em>. 2023 Feb 16;15(2):667. <span style=\"color: #808000;\"><strong><a style=\"color: #808000;\" href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/36839987\/#new_tab\">doi: 10.3390\/pharmaceutics15020667<\/a><\/strong><\/span>. PMID: 36839987<\/li>\n<li>Varela-Rey I, de la Iglesia D, San Bruno-Ruz A, Mejuto-Fern\u00e1ndez R, Monteser\u00edn-Ron L, L\u00f3pez-Diaz J, Garc\u00eda-Salom P, Gonz\u00e1lez-Cantalapiedra A, Manuel Brea J, Pi\u00f1a-M\u00e1rquez R, D\u00edaz-Tom\u00e9 V, Gonz\u00e1lez-Barcia M, Zarra-Ferro I, Mondelo-Garc\u00eda C, Dominguez-Mu\u00f1oz E, Otero-Espinar F, Fern\u00e1ndez-Ferreiro A. <strong>Design and biopharmaceutical preclinical characterisation of a new thermosensitive hydrogel for the removal of gastric polyps.<\/strong> <em>Int J Pharm.<\/em> 2023 Mar 25;635:122706. <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/36803925\/\"><span style=\"color: #808000;\"><strong>doi: 10.1016\/j.ijpharm.2023.122706<\/strong><\/span><\/a>. PMID: 36803925<\/li>\n<li>Castro-Balado A, Band\u00edn-Vilar E, Cuartero-Mart\u00ednez A, Garc\u00eda-Quintanilla L, Hermelo-Vidal G, Garc\u00eda-Otero X, Rodr\u00edguez-Mart\u00ednez L, Mateos J, Hern\u00e1ndez-Blanco M, Aguiar P, Zarra-Ferro I, Gonz\u00e1lez-Barcia M, Mondelo-Garc\u00eda C, Otero-Espinar FJ, Fern\u00e1ndez-Ferreiro A. <strong>Cysteamine Eye Drops in Hyaluronic Acid Packaged in Innovative Single-Dose Systems: Stability and Ocular Biopermanence.<\/strong> <em>Pharmaceutics<\/em>. 2022 Oct 15;14(10):2194. <span style=\"color: #808000;\"><strong><a style=\"color: #808000;\" href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/36297629\/\">doi: 10.3390\/pharmaceutics14102194<\/a><\/strong><\/span>. PMID: 36297629<\/li>\n<li>Band\u00edn-Vilar E, Garc\u00eda-Quintanilla L, Castro-Balado A, Zarra-Ferro I, Gonz\u00e1lez-Barcia M, Campos-Toimil M, Mangas-Sanjuan V, Mondelo-Garc\u00eda C, Fern\u00e1ndez-Ferreiro A. <strong>A Review of Population Pharmacokinetic Analyses of Linezolid.<\/strong> <em>Clin Pharmacokinet.<\/em> 2022 Jun;61(6):789-817. <span style=\"color: #808000;\"><strong><a style=\"color: #808000;\" href=\"https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC9192929\/\">doi: 10.1007\/s40262-022-01125-2<\/a><\/strong><\/span>. Epub 2022 Jun 14. PMID: 35699914<\/li>\n<li>Garc\u00eda-Quintanilla L, Rodr\u00edguez-Mart\u00ednez L, Band\u00edn-Vilar E, Gil-Mart\u00ednez M, Gonz\u00e1lez-Barcia M, Mondelo-Garc\u00eda C, Fern\u00e1ndez-Ferreiro A, Mateos J. <strong>Recent Advances in Proteomics-Based Approaches to Studying Age-Related Macular Degeneration: A Systematic Review.<\/strong> <em>Int J Mol Sci<\/em>. 2022 Nov 25;23(23):14759. <span style=\"color: #808000;\"><strong><a style=\"color: #808000;\" href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/36499086\/\">doi: 10.3390\/ijms232314759.<\/a><\/strong><\/span> PMID: 36499086<\/li>\n<\/ul>\n<p>[\/et_pb_toggle][et_pb_toggle title=&#8221;Group website&#8221; disabled_on=&#8221;off|off|off&#8221; admin_label=&#8221;Web del grupo&#8221; _builder_version=&#8221;4.19.4&#8243; _module_preset=&#8221;default&#8221; body_font=&#8221;|300|||||||&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<blockquote class=\"wp-embedded-content\" data-secret=\"D6YPX0p5yf\"><p><a href=\"https:\/\/mibiopharm.com\/unidad-farmacia-hospitalaria\/\">I+i en Farmacia Hospitalaria<\/a><\/p><\/blockquote>\n<p><iframe loading=\"lazy\" class=\"wp-embedded-content\" sandbox=\"allow-scripts\" security=\"restricted\" style=\"position: absolute; visibility: hidden;\" title=\"\u00abI+i en Farmacia Hospitalaria\u00bb \u2014 Farmachus Lab\" src=\"https:\/\/mibiopharm.com\/unidad-farmacia-hospitalaria\/embed\/#?secret=PQLZxhyhPc#?secret=D6YPX0p5yf\" data-secret=\"D6YPX0p5yf\" width=\"600\" height=\"338\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\"><\/iframe><\/p>\n<p>[\/et_pb_toggle][\/et_pb_column][et_pb_column type=&#8221;1_3&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text admin_label=&#8221;Investigador\/a l\u00edder&#8221; _builder_version=&#8221;4.21.0&#8243; _module_preset=&#8221;default&#8221; text_text_color=&#8221;#FFFFFF&#8221; header_text_color=&#8221;#FFFFFF&#8221; header_2_text_align=&#8221;left&#8221; header_2_text_color=&#8221;#FFFFFF&#8221; background_color=&#8221;#10294c&#8221; custom_margin=&#8221;0px||||false|false&#8221; custom_padding=&#8221;6px||0px|6px|false|false&#8221; locked=&#8221;off&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h2>Lead researcher<\/h2>\n<p>[\/et_pb_text][et_pb_text admin_label=&#8221;WP Team (cambiar s\u00f3 a ID pola do l\u00edder de equipo)&#8221; _builder_version=&#8221;4.21.0&#8243; _module_preset=&#8221;default&#8221; locked=&#8221;off&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<div class=\"sp-wp-team-pro-wrapper wp-team-pro-preloader\" >\n\n<div id=\"sptp-44188\" class=\"sp-team-pro sptp-section sptp-modal pagination_number sptp-even\" >\n\n\t<div class=\"sp-team-pro-page-loading-image\"><\/div>\n\t<div class=\"sptp-grid\">\n\t\t<div class=\"sptp-row  \">\n\t\t\t\t\t<div class=\"sp-team-pro-item sptp-col-lg-1 sptp-col-md-1 sptp-col-sm-1 sptp-col-xs-1\"\n\t\t\t data-member=\"44187\">\n\t\t\t\t<div class=\"sptp-member  border-bg-around-member sptp-square\">\n\t<a class=\"sptp-member-avatar  sptp-popup-trigger \"  href=javascript:void(0) target=_blank >\n\t<div class=\"sptp-member-avatar-img-area\" data-id=\"44187\">\n\t\t<div class=\"sptp-member-avatar-img sptp-square sptp-icon-on-image none \">\n\t\t\t<div class=\"sptp-overflow-h\">\n\t\t\t\t\t\t\t\t\t<div class=\"sptp-icon text-center\">\n\t\t\t\t\t<i class=\"fa fa-plus\"><\/i>\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<img loading=\"lazy\" decoding=\"async\" class=\"sptp_default_img\" srcset=\"https:\/\/www.idisantiago.es\/wp-content\/plugins\/wp-team-pro\/src\/Frontend\/img\/Placeholder-Image.png\" src=\"https:\/\/www.idisantiago.es\/wp-content\/plugins\/wp-team-pro\/src\/Frontend\/img\/Placeholder-Image.png\" alt=\"Anxo Fern\u00e1ndez Ferreiro\" width=\"600\" height=\"450\">\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t<\/div>\n<\/a>\n\t<div class=\"sptp-member-name \">\n\t\t<h2>\n\t\t\t\t\tAnxo Fern\u00e1ndez Ferreiro\t\t\t\t<\/h2>\n\t<\/div>\n<div class=\"sptp-member-profession\">\n\t\t\t<h4>Investigador l\u00edder del grupo E034 \u2013 FarmaCHUSLab<\/h4>\n\t<\/div>\n<div class=\"sptp-member-email\">\n\n<i class=\"fa fa-envelope\"><\/i>\t<a href=\"#0\"  class=\"\">\n\t\t<span>Anxo.Fernandez.Ferreiro@sergas.es<\/span>\n\t<\/a>\n\t<\/div>\n<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div> <!-- end row -->\n\t<\/div> <!-- end grid -->\n\t\t\t<\/div>\n<\/div>\n\n<p>[\/et_pb_text][et_pb_text admin_label=&#8221;Investigador\/a l\u00edder&#8221; _builder_version=&#8221;4.21.0&#8243; _module_preset=&#8221;default&#8221; text_text_color=&#8221;#FFFFFF&#8221; header_text_color=&#8221;#FFFFFF&#8221; header_2_text_align=&#8221;left&#8221; header_2_text_color=&#8221;#FFFFFF&#8221; background_color=&#8221;#10294c&#8221; custom_margin=&#8221;0px||||false|false&#8221; custom_padding=&#8221;6px||0px|6px|false|false&#8221; locked=&#8221;off&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h2>Colead researcher<\/h2>\n<p>[\/et_pb_text][et_pb_text admin_label=&#8221;WP Team (cambiar s\u00f3 a ID pola do l\u00edder de equipo)&#8221; _builder_version=&#8221;4.21.0&#8243; _module_preset=&#8221;default&#8221; locked=&#8221;off&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<div class=\"sp-wp-team-pro-wrapper wp-team-pro-preloader\" >\n\n<div id=\"sptp-40915\" class=\"sp-team-pro sptp-section sptp-modal pagination_number sptp-even\" >\n\n\t<div class=\"sp-team-pro-page-loading-image\"><\/div>\n\t<div class=\"sptp-grid\">\n\t\t<div class=\"sptp-row  \">\n\t\t\t\t\t<div class=\"sp-team-pro-item sptp-col-lg-1 sptp-col-md-1 sptp-col-sm-1 sptp-col-xs-1\"\n\t\t\t data-member=\"44040\">\n\t\t\t\t<div class=\"sptp-member  border-bg-around-member sptp-square\">\n\t<a class=\"sptp-member-avatar  sptp-popup-trigger \"  href=javascript:void(0) target=_blank >\n\t<div class=\"sptp-member-avatar-img-area\" data-id=\"44040\">\n\t\t<div class=\"sptp-member-avatar-img sptp-square sptp-icon-on-image none \">\n\t\t\t<div class=\"sptp-overflow-h\">\n\t\t\t\t\t\t\t\t\t<div class=\"sptp-icon text-center\">\n\t\t\t\t\t<i class=\"fa fa-plus\"><\/i>\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<img loading=\"lazy\" decoding=\"async\" class=\"sptp_default_img\" srcset=\"https:\/\/www.idisantiago.es\/wp-content\/plugins\/wp-team-pro\/src\/Frontend\/img\/Placeholder-Image.png\" src=\"https:\/\/www.idisantiago.es\/wp-content\/plugins\/wp-team-pro\/src\/Frontend\/img\/Placeholder-Image.png\" alt=\"Cristina Mondelo Garc\u00eda\" width=\"600\" height=\"450\">\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t<\/div>\n<\/a>\n\t<div class=\"sptp-member-name \">\n\t\t<h2>\n\t\t\t\t\tCristina Mondelo Garc\u00eda\t\t\t\t<\/h2>\n\t<\/div>\n<div class=\"sptp-member-profession\">\n\t\t\t<h4>Investigadora col\u00edder del grupo E034 - FarmaCHUSLab<\/h4>\n\t<\/div>\n<div class=\"sptp-member-email\">\n\n<i class=\"fa fa-envelope\"><\/i>\t<a href=\"#0\"  class=\"\">\n\t\t<span>cristina.mondelo.garcia@sergas.es<\/span>\n\t<\/a>\n\t<\/div>\n<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div> <!-- end row -->\n\t<\/div> <!-- end grid -->\n\t\t\t<\/div>\n<\/div>\n\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u00c1REA: PLATAFORMAS Y METODOLOG\u00cdAObjectives In the field of clinical and translational research, the interests of our research group, made up mainly of members of the Pharmacy Service of the Santiago [&hellip;]<\/p>\n","protected":false},"author":11,"featured_media":30652,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_et_pb_use_builder":"on","_et_pb_old_content":"","_et_gb_content_width":"","inline_featured_image":false,"footnotes":""},"project_category":[514],"project_tag":[],"class_list":["post-18983","project","type-project","status-publish","has-post-thumbnail","hentry","project_category-plataformas-y-metodologia-en"],"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/www.idisantiago.es\/en\/wp-json\/wp\/v2\/project\/18983","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.idisantiago.es\/en\/wp-json\/wp\/v2\/project"}],"about":[{"href":"https:\/\/www.idisantiago.es\/en\/wp-json\/wp\/v2\/types\/project"}],"author":[{"embeddable":true,"href":"https:\/\/www.idisantiago.es\/en\/wp-json\/wp\/v2\/users\/11"}],"replies":[{"embeddable":true,"href":"https:\/\/www.idisantiago.es\/en\/wp-json\/wp\/v2\/comments?post=18983"}],"version-history":[{"count":42,"href":"https:\/\/www.idisantiago.es\/en\/wp-json\/wp\/v2\/project\/18983\/revisions"}],"predecessor-version":[{"id":45913,"href":"https:\/\/www.idisantiago.es\/en\/wp-json\/wp\/v2\/project\/18983\/revisions\/45913"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.idisantiago.es\/en\/wp-json\/wp\/v2\/media\/30652"}],"wp:attachment":[{"href":"https:\/\/www.idisantiago.es\/en\/wp-json\/wp\/v2\/media?parent=18983"}],"wp:term":[{"taxonomy":"project_category","embeddable":true,"href":"https:\/\/www.idisantiago.es\/en\/wp-json\/wp\/v2\/project_category?post=18983"},{"taxonomy":"project_tag","embeddable":true,"href":"https:\/\/www.idisantiago.es\/en\/wp-json\/wp\/v2\/project_tag?post=18983"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}